That's a wrap! Thank you to everyone who participated in #ISTH2022, in-person in London, or at home virtually. See you all next year in Montreal for #ISTH2023!

Y en el turno de la Dra. Julia Oto, presenta en #Hemato2022 un nuevo mecanismo por el que los pacientes con déficit de proteína C tienen una mayor NETosis que podría agravar su riesgo inherente de #trombosis SETH Trombosis y Hemostasia IIS La Fe HospitalLaFe

Exitazo de congreso, la Dra. Julia Oto presenta en #Hemato2022 la reducción del anticoagulante natural, proteina C activada circulante, como posible nuevo mecanismo protumoral SETH Trombosis y Hemostasia IIS La Fe HospitalLaFe

Y por último, aquí tenemos@nuestros pósters! #Hemato2022 SETH Trombosis y Hemostasia IIS La Fe HospitalLaFe Julia Oto Raquel Herranz

Hasta lueho #Hemato2022, Nos vemos en Sevilla 2023!!! SETH Trombosis y Hemostasia IIS La Fe HospitalLaFe Julia Oto Raquel Herranz

Mit Alexander von Humboldt (Humboldt-Stiftung) an der TU Chemnitz

Our Uniklinik Münster Humboldt-Stiftung fellowship recipients Jessica Oyie & Julia Oto enjoy presenting their research projects on #syndecans in #ovariancancer & #breastcancer at the AvH network meeting in Chemnitz! @WWU_Muenster ISMB DGMB Glycans in Cancer #ECM #glycotime

New paper on Neutrophil Extracellular Traps and Ovarian Cancer. Great collaboration of HOSPITAL GENERAL & Uniklinik Münster! Julia Oto Humboldt-Stiftung mdpi.com/2208634 IJMS MDPI #ovariancancer #nets @KrebsNRW Deutsche Gesellschaft für Endokrinologie DGGEF #NETosis #neutrophils #Cancer

New review on #syndecans in #ovariancancer by Marie Skłodowska-Curie Actions EU project HEPINIB Uniklinik Münster. mdpi.com/2334462 Great work by Humboldt-Stiftung fellow Julia Oto. European Research Executive Agency ISMB DGMB Glycans in Cancer Extracellular Matrix News Deutsche Gesellschaft für Endokrinologie DGGEF Target Ovarian Cancer @ovariancancerco

doi.org/10.3390/ijms24… doi.org/10.1136/ijgc-2… doi.org/10.3390/cells1… doi.org/10.3390/cancer…

doi.org/10.3390/ijms24… doi.org/10.1136/ijgc-2… doi.org/10.3390/cells1… doi.org/10.3390/cancer… doi.org/10.1016/j.fert… doi.org/10.1245/s10434… doi.org/10.1016/j.ajog…

doi.org/10.1111/odi.15… doi.org/10.1136/ijgc-2… doi.org/10.3390/ijms24… doi.org/10.1002/ctm2.1… doi.org/10.3389/fimmu.… doi.org/10.1111/odi.14… doi.org/10.1245/s10434… doi.org/10.1016/j.oral… doi.org/10.1016/j.msec… doi.org/10.1016/j.oral…